IAVI and Biofabri dose first adults and teens in TB vaccine trial
IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...
Designing self-destructing bacteria make effective tuberculosis vaccines: Study
Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...
Oxford Mail1d
Oxford researchers awarded £5m to tackle drug-resistant TB
Seventeen Oxford University researchers have been awarded £5 million to develop new therapies for drug-resistant tuberculosis.
Hosted on MSN2d
Researchers Develop Mycobacteria Strains with Kill Switches for Safer TB Vaccines
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...
Karachi Safari Park Elephants Suspected of Having Human-to-Animal Fatal Disease
In a concerning development, two female elephants at Karachi’s Safari Park, Malaika and Madhubala, have been diagnosed with ...
technologynetworks4d
Controlled Kill Switches Improve TB Vaccine Safety
Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...
The Financial Express5d
New mRNA vaccine against tuberculosis effectively boosts immunity, study reveals
Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...